Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

the Chroma and Spectri Study Investigators

Research output: Contribution to journalArticlepeer-review

162 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences